financetom
Market
financetom
/
Market
/
Top Midday Stories: 3M Shares Rise on Strong Guidance; Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising
News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities
Top Midday Stories: 3M Shares Rise on Strong Guidance; Novo Nordisk Sues Eli Lilly Over GLP-1 Advertising
Jul 21, 2026 9:17 AM

11:49 AM EDT, 07/21/2026 (MT Newswires) -- All three major US stock indexes were up in late-morning trading Tuesday, as investors focused on some strong corporate earnings reports.

In company news, 3M ( MMM ) reported Q2 adjusted earnings Tuesday of $2.40 per share, up from $2.16 a year earlier and above the FactSet consensus analyst estimate of $2.25. Second-quarter revenue was $6.5 billion, up from $6.34 billion a year ago and above the FactSet consensus of $6.40 billion. For fiscal 2026, the company expects adjusted EPS of $$8.80 to $8.95, up from its previous outlook of $8.50 to $8.70 and above the FactSet consensus of $8.74. 3M ( MMM ) shares were up 8.7% around midday.

Novo Nordisk ( NVO ) said Tuesday it filed a lawsuit against Eli Lilly ( LLY ) in the US District Court for the District of New Jersey alleging the drugmaker's advertising for Zepbound and Mounjaro violates federal and state false advertising and unfair competition laws. Novo shares were down 0.3%, while Lilly shares were up 1.3%.

Utz Brands ( UTZ ) has entered into a definitive agreement through which Intersnack Group will acquire all of its outstanding common stock for $14.25 per share in cash and take it private, the companies said Tuesday. The price represents an enterprise value of about $2.9 billion and a 91% premium over Utz's closing price on July 20, the companies said. The deal is expected to close in Q4, subject to regulatory and other conditions, they said. Utz shares were up 89.5%.

Danaher ( DHR ) reported Q2 adjusted net earnings Tuesday of $1.94 per diluted share, up from $1.80 a year earlier and above the FactSet consensus of $1.84. Second-quarter sales were $6.27 billion, up from $5.94 billion a year ago and above the FactSet consensus of $6.11 billion. For full-year 2026, the company raised its adjusted diluted EPS guidance to $8.45 to $8.60 from $8.35 to $8.55. Analysts polled by FactSet expect $8.45. Danaher ( DHR ) shares were down $14.1%.

General Motors ( GM ) reported Q2 adjusted diluted EPS Tuesday of $3.57, up from $2.53 a year earlier and above the FactSet consensus of $3.19. Second-quarter revenue was $48.03 billion, up from $47.12 billion a year ago and above the FactSet consensus of $47.01 billion. For 2026, the company expects adjusted EPS of $12 to $14, compared with the FactSet consensus of $12.97. GM shares were up 4.0%.

MSCI ( MSCI ) reported Q2 adjusted EPS of $4.94, up from $4.17 a year earlier but below the FactSet consensus of $4.99. Second-quarter operating revenue was $867 million, up from $772.7 million a year ago but below the FactSet consensus of $870.7 million. MSCI ( MSCI ) shares were down 8.7%.

Price: 49.45, Change: -0.16, Percent Change: -0.33

Comments
Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.
Sign up to post
Sort by
Show More Comments
Related Articles >
Nvidia Earnings in Focus as US Equity Futures Post Narrow Gains Pre-Bell
Nvidia Earnings in Focus as US Equity Futures Post Narrow Gains Pre-Bell
Nov 21, 2024
08:50 AM EST, 11/21/2024 (MT Newswires) -- US equity futures were cautiously higher ahead of Thursday's opening bell as traders digested earnings and guidance from artificial intelligence chipmaker Nvidia ( NVDA ) . Dow Jones Industrial Average futures rose 0.4%, S&P 500 futures gained 0.4%, and Nasdaq futures were up 0.3%. Nvidia ( NVDA ) reported late Wednesday fiscal Q3...
Sector Update: Health Care
Sector Update: Health Care
Nov 21, 2024
08:52 AM EST, 11/21/2024 (MT Newswires) -- Health care stocks rose in pre-bell hours Thursday with the Health Care Select Sector SPDR Fund (XLV) 0.1% higher and the iShares Biotechnology ETF (IBB) up 0.3% recently. Zymeworks ( ZYME ) and Jazz Pharmaceuticals ( JAZZ ) said they have received accelerated approval for Ziihera from the US Food and Drug Administration...
Sector Update: Tech
Sector Update: Tech
Nov 21, 2024
08:45 AM EST, 11/21/2024 (MT Newswires) -- Technology stocks were edging higher premarket Thursday as the Technology Select Sector SPDR Fund (XLK) was up 0.7% and the SPDR S&P Semiconductor ETF (XSD) marginally advanced. Snowflake (SNOW) shares rose past 24% after the company reported fiscal Q3 earnings and sales above analyst expectations. ...
US STOCKS-Wall St set for higher open after jobless claims data, Nvidia results
US STOCKS-Wall St set for higher open after jobless claims data, Nvidia results
Nov 21, 2024
(For a Reuters live blog on U.S., UK and European stock markets, click or type LIVE/ in a news window.) * Snowflake jumps after raising annual product revenue forecast * Deere shares up after Q4 profit beats estimates * Crypto stocks gain as bitcoin prices near $100,000 * Weekly jobless claims stand at 213,000 * Futures: Dow up 0.45%, S&P...
Copyright 2023-2026 - www.financetom.com All Rights Reserved